
The LIPOCAT study analyzed 933 type 2 diabetes (T2D) patients using advanced 1H-NMR lipoprotein and glycoprotein profiling. Elevated VLDL-C, IDL-TG, LDL-TG, and glycoproteins A and B were linked to cardiovascular events (CVE). Adding these advanced biomarkers to traditional models improved CVE prediction, with AUROC reaching 0.756. Findings were validated in an independent cohort.
Like
Save
Share